Ceva Opens New Reference for Autogenous Vaccine Manufacture

Ceva has announced the opening of a new reference facility. This facility is dedicated to the manufacture of autogenous vaccines. The development was reported by the industry outlet 3tres3.com. Autogenous vaccines are custom-made vaccines created from specific pathogens isolated from animals. This new reference center likely aims to set a standard for production quality. It highlights Ceva's continued investment in specialized veterinary health solutions. The facility will support the production of tailored vaccines for specific disease outbreaks. This move strengthens the company's capabilities in the animal health sector.